JP2019533018A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019533018A5 JP2019533018A5 JP2019542351A JP2019542351A JP2019533018A5 JP 2019533018 A5 JP2019533018 A5 JP 2019533018A5 JP 2019542351 A JP2019542351 A JP 2019542351A JP 2019542351 A JP2019542351 A JP 2019542351A JP 2019533018 A5 JP2019533018 A5 JP 2019533018A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- dosage form
- dosage forms
- dosage
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 208000037976 chronic inflammation Diseases 0.000 claims description 7
- 230000006020 chronic inflammation Effects 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 210000003630 histaminocyte Anatomy 0.000 claims description 4
- 229940124597 therapeutic agent Drugs 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 230000000087 stabilizing effect Effects 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- IYSYPCSSDZBWHN-UHFFFAOYSA-N Nor-ketotifen Chemical compound C1=2C=CSC=2C(=O)CC2=CC=CC=C2C1=C1CCNCC1 IYSYPCSSDZBWHN-UHFFFAOYSA-N 0.000 claims 2
- 206010010741 Conjunctivitis Diseases 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000006207 intravenous dosage form Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 208000029081 mast cell activation syndrome Diseases 0.000 claims 1
- 208000008585 mastocytosis Diseases 0.000 claims 1
- 239000006186 oral dosage form Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662409557P | 2016-10-18 | 2016-10-18 | |
| US62/409,557 | 2016-10-18 | ||
| PCT/US2017/057078 WO2018075574A1 (en) | 2016-10-18 | 2017-10-18 | Mast cell stabilizers for treatment of chronic inflammatory conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019533018A JP2019533018A (ja) | 2019-11-14 |
| JP2019533018A5 true JP2019533018A5 (OSRAM) | 2020-12-03 |
Family
ID=62019018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019542351A Pending JP2019533018A (ja) | 2016-10-18 | 2017-10-18 | 慢性炎症状態の処置の為の肥満細胞安定剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11478463B2 (OSRAM) |
| EP (1) | EP3528809A4 (OSRAM) |
| JP (1) | JP2019533018A (OSRAM) |
| CA (1) | CA3040420A1 (OSRAM) |
| WO (1) | WO2018075574A1 (OSRAM) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190073365A (ko) | 2016-09-08 | 2019-06-26 | 이메르고 테라퓨틱스, 인코포레이티드 | 사이토카인 과분비 및 바이러스성 감염의 치료를 위한 비만 세포 안정화제 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6878715B1 (en) | 1994-02-18 | 2005-04-12 | Cell Therapeutics, Inc. | Therapeutic compounds for inhibiting interleukin-12 signals and method for using same |
| AU6165798A (en) | 1997-02-18 | 1998-09-08 | Bridge Pharma, Inc. | Non-sedating histamine antagonist compounds, compositions and methods of use thereof |
| EP0977568B1 (en) | 1997-04-03 | 2006-03-08 | Bridge Pharma, Inc. | Benzocycloheptathiophene compounds |
| US6207684B1 (en) | 1997-06-09 | 2001-03-27 | Bridge Pharma, Inc. | Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use |
| PL353586A1 (en) | 1999-09-13 | 2003-12-01 | Bridge Pharma, Inc.Bridge Pharma, Inc. | Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| US20050249735A1 (en) | 2000-08-07 | 2005-11-10 | Centocor, Inc. | Methods of treating ankylosing spondylitis using anti-TNF antibodies and peptides of human tumor necrosis factor |
| US20030118670A1 (en) | 2001-07-11 | 2003-06-26 | Smith C. Steven | Novel composition and method for altering allergenic protein in the environment |
| US20060084695A1 (en) | 2004-04-29 | 2006-04-20 | John Griffin | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
| US20080311122A1 (en) | 2005-11-28 | 2008-12-18 | Medimmune, Llc | Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof |
| CN101541303A (zh) | 2006-09-29 | 2009-09-23 | 庄臣及庄臣视力保护公司 | 用于治疗眼变态反应性的方法和眼科装置 |
| US20080139531A1 (en) | 2006-12-04 | 2008-06-12 | Alcon Manufacturing Ltd. | Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair |
| US20100166804A1 (en) | 2007-05-23 | 2010-07-01 | Dennis Penn | Methods |
| WO2009088570A1 (en) | 2008-01-04 | 2009-07-16 | Sirion Therapeutics, Inc. | Stable aqueous cyclosporin compositions |
| WO2009142772A2 (en) * | 2008-05-23 | 2009-11-26 | Mastcell Pharmaceuticals, Inc. | Methods and treatment for allergies and inflammation associated with gastrointestinal diseases |
| WO2010047681A1 (en) | 2008-10-24 | 2010-04-29 | Bridge Pharma, Inc. | Treating xerophthalmia with norketotifen |
| US8765787B2 (en) | 2008-11-21 | 2014-07-01 | Bridge Pharma, Inc. | Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen |
| CA2754996A1 (en) | 2009-03-17 | 2010-09-23 | Aciex Therapeutics, Inc. | Ophthalmic formulations of ketotifen and methods of use |
| WO2010106016A1 (en) | 2009-03-17 | 2010-09-23 | Glaxo Group Limited | Pyrimidine derivatives used as itk inhibitors |
| EP2506843A4 (en) | 2009-12-02 | 2013-04-17 | Bridge Pharma Inc | TREATMENT OF THE DRY EYE WITH COMPOUNDS TO INCREASE MOMENTUM DRY SECRETION |
| US8841417B2 (en) | 2010-05-14 | 2014-09-23 | Abbvie Inc. | IL-1 binding proteins |
| UY33492A (es) | 2010-07-09 | 2012-01-31 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
| SG10201505454SA (en) | 2011-07-13 | 2015-09-29 | Abbvie Inc | Methods and compositions for treating asthma using anti-il-13 antibodies |
| US8778971B2 (en) | 2012-10-23 | 2014-07-15 | Bridge Pharma, Inc. | Medicinal treatment of dermal diseases in companion animals |
| US8557846B1 (en) | 2012-10-23 | 2013-10-15 | Bridge Pharma, Inc. | Medicinal treatment of dermal diseases in dogs |
| US20150272941A1 (en) | 2012-10-30 | 2015-10-01 | Bridge Pharma, Inc. | Medicinal treatment of chronic pulmonary inflammatory diseases with norketotifen |
| US20140120121A1 (en) | 2012-10-30 | 2014-05-01 | Bridge Pharma, Inc. | Medicinal treatment of atopic inflammatory diseases |
| US9439895B2 (en) | 2013-08-06 | 2016-09-13 | Bridge Pharma, Inc. | Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients |
| US9138431B2 (en) | 2013-08-06 | 2015-09-22 | Bridge Pharma, Inc. | Methods of treatment of histamine H-4 receptor-related pruritus |
| US9345697B2 (en) | 2013-08-06 | 2016-05-24 | Bridge Pharma, Inc. | Methods of treatment of non-histaminic pruritus |
| EP3653207A1 (en) * | 2014-02-10 | 2020-05-20 | Respivant Sciences GmbH | Mast cell stabilizers treatment for systemic disorders |
| CN106102778A (zh) | 2014-03-27 | 2016-11-09 | 宝丽制药股份有限公司 | 乳化剂型的组合物的制造方法 |
| WO2016011254A1 (en) * | 2014-07-16 | 2016-01-21 | Henry J. Legere Md, Pa | Combinations of antihistamines and leukotriene antagonists and methods of use thereof |
| JP2017524382A (ja) | 2014-08-01 | 2017-08-31 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 偽アレルギー薬物反応を検出するためおよび有害反応を予防する遮断薬を同定するためのｍｒｇｐｒｘ２／ｍｒｇｐｒｂ２発現細胞ベースのアッセイ |
| EP3267794B1 (en) | 2015-02-13 | 2020-09-09 | Yale University | Biaryltriazole inhibitors of macrophage migration inhibitory factor |
| WO2017035418A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Disubstituted compounds for treatment of immune and inflammatory disorders |
| US9694003B2 (en) * | 2015-10-15 | 2017-07-04 | Bridge Pharma, Inc. | Formulations and methods for treating high intraocular pressure |
| KR20190073365A (ko) | 2016-09-08 | 2019-06-26 | 이메르고 테라퓨틱스, 인코포레이티드 | 사이토카인 과분비 및 바이러스성 감염의 치료를 위한 비만 세포 안정화제 |
-
2017
- 2017-10-18 US US16/341,277 patent/US11478463B2/en active Active
- 2017-10-18 JP JP2019542351A patent/JP2019533018A/ja active Pending
- 2017-10-18 WO PCT/US2017/057078 patent/WO2018075574A1/en not_active Ceased
- 2017-10-18 EP EP17861667.8A patent/EP3528809A4/en active Pending
- 2017-10-18 CA CA3040420A patent/CA3040420A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201490279A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| WO2020102804A3 (en) | Pharmaceutical combination for treatment of cancer | |
| JP2019529541A5 (OSRAM) | ||
| AR085662A1 (es) | Metodos y composiciones para tratar la hiperuricemia y trastornos metabolicos asociados con la hiperuricemia | |
| EA201490163A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| MX2010005342A (es) | Compuestos indola y metodos para tratar el dolor visceral. | |
| EA201790406A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| PH12012501480A1 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| RU2019110150A (ru) | Стабилизаторы тучных клеток лечения гиперцитокинемии и вирусной инфекции | |
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| JP2013522303A5 (OSRAM) | ||
| IL300151A (en) | Combinations for the treatment of cancer | |
| JP2014516942A5 (OSRAM) | ||
| PE20091672A1 (es) | Nueva dosificacion y formulacion | |
| RU2017116740A (ru) | Комбинации для лечения рассеянного склероза | |
| JP2016512817A5 (OSRAM) | ||
| JP2013541583A5 (OSRAM) | ||
| RU2016132762A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| JP2014504636A5 (OSRAM) | ||
| JP2011500589A5 (OSRAM) | ||
| JP2014148552A5 (OSRAM) | ||
| JP2016505050A5 (OSRAM) | ||
| JP2019533018A5 (OSRAM) | ||
| RU2016103098A (ru) | Способ предотвращения и/или лечения хронической травматической энцефалопатии - ii | |
| RU2010154623A (ru) | Производные 1-аминоалкилциклогексана для лечения расстройств сна |